[go: up one dir, main page]

AR064544A1 - Uso de derivados de mononitrato de dianhidrohexita como agentes reductores de la hipertension ocular - Google Patents

Uso de derivados de mononitrato de dianhidrohexita como agentes reductores de la hipertension ocular

Info

Publication number
AR064544A1
AR064544A1 ARP070105912A AR064544A1 AR 064544 A1 AR064544 A1 AR 064544A1 AR P070105912 A ARP070105912 A AR P070105912A AR 064544 A1 AR064544 A1 AR 064544A1
Authority
AR
Argentina
Prior art keywords
ocular hypertension
reducing agents
mononitrate derivatives
dianhydrohexite mononitrate
dianhydrohexite
Prior art date
Application number
Other languages
English (en)
Inventor
Coy Francisco Pubill
Mancini Marisabel Mourelle
Moliner Jose Repolles
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of AR064544A1 publication Critical patent/AR064544A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere al uso de un compuesto de formula (1) o un tautomero, una sal farmacéuticamente aceptable, un profármaco o un solvato del mismo, como ingrediente o ingredientes activos en la fabricacion de una composicion farmacéutica para la prevencion y/o tratamiento de enfermedades oftalmologicas mediadas por hipertension ocular.
ARP070105912 2006-12-28 2007-12-27 Uso de derivados de mononitrato de dianhidrohexita como agentes reductores de la hipertension ocular AR064544A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06038338 2006-12-28

Publications (1)

Publication Number Publication Date
AR064544A1 true AR064544A1 (es) 2009-04-08

Family

ID=40639642

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105912 AR064544A1 (es) 2006-12-28 2007-12-27 Uso de derivados de mononitrato de dianhidrohexita como agentes reductores de la hipertension ocular

Country Status (1)

Country Link
AR (1) AR064544A1 (es)

Similar Documents

Publication Publication Date Title
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
AR062397A1 (es) Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento de fibrosis
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
WO2007046868A3 (en) Thiazolidine derivatives and their uses as therapeutic agents
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
AR064543A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0611705A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
ECSP066878A (es) [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
UA96575C2 (en) Process for the preparation of olmesartan medoxomil
AR062395A1 (es) Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares
WO2006108682A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents
AR032138A1 (es) Derivados de 6-hidroxi-indazol, una composicion oftalmica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de glaucoma
BRPI0514735B8 (pt) derivados de pirimidino sulfonamida como moduladores do receptor de quimiocina.
BRPI0518993A2 (pt) composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
WO2009042094A3 (en) Hiv protease inhibitors
WO2008136034A3 (en) Ophthalmic compositions for the treatment of ocular hypertension and glaucoma

Legal Events

Date Code Title Description
FB Suspension of granting procedure